CTLA4 and neoplasm: PD-L1 positivity has been reported from 19% to 64% [78]; herein, the IM tumor samples showed 20% PD-L1 positivity, 30% intT CTLA-4, and 9% strml CTLA-4 expression, which are in agreement with previous reports.